GB201707856D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB201707856D0 GB201707856D0 GBGB1707856.9A GB201707856A GB201707856D0 GB 201707856 D0 GB201707856 D0 GB 201707856D0 GB 201707856 A GB201707856 A GB 201707856A GB 201707856 D0 GB201707856 D0 GB 201707856D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1707856.9A GB201707856D0 (en) | 2017-05-16 | 2017-05-16 | Compounds |
| US16/613,837 US11142520B2 (en) | 2017-05-16 | 2018-05-16 | LDHA activity inhibitors |
| EP18727384.2A EP3625225B1 (en) | 2017-05-16 | 2018-05-16 | Ldha activity inhibitors |
| ES18727384T ES2923652T3 (es) | 2017-05-16 | 2018-05-16 | Inhibidores de la actividad LDHA |
| JP2020514351A JP2020520388A (ja) | 2017-05-16 | 2018-05-16 | Ｌｄｈａ活性阻害剤 |
| PCT/GB2018/051333 WO2018211277A1 (en) | 2017-05-16 | 2018-05-16 | Ldha activity inhibitors |
| CN201880034909.5A CN110709393A (zh) | 2017-05-16 | 2018-05-16 | Ldha活性抑制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1707856.9A GB201707856D0 (en) | 2017-05-16 | 2017-05-16 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201707856D0 true GB201707856D0 (en) | 2017-06-28 |
Family
ID=59201440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1707856.9A Ceased GB201707856D0 (en) | 2017-05-16 | 2017-05-16 | Compounds |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11142520B2 (enExample) |
| EP (1) | EP3625225B1 (enExample) |
| JP (1) | JP2020520388A (enExample) |
| CN (1) | CN110709393A (enExample) |
| ES (1) | ES2923652T3 (enExample) |
| GB (1) | GB201707856D0 (enExample) |
| WO (1) | WO2018211277A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020221899A1 (en) * | 2019-05-02 | 2020-11-05 | Université Catholique de Louvain | Lactate dehydrogenase inhibitor polypeptides for use in the treatment of cancer |
| US20230346862A1 (en) | 2022-05-02 | 2023-11-02 | Athanor Biosciences, Inc. | Cancer eradicating - bio-nanoparticles (ce-bnp) |
| WO2025011479A1 (en) * | 2023-07-13 | 2025-01-16 | Meta Pharmaceuticals (Hk) Limited | Pyrazole based inhibitors of LDH and their use in immune and inflammatory diseases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69430671T2 (de) | 1993-11-19 | 2002-11-21 | Parke, Davis & Company | 5,6-dihydropyron derivate als protease inhibitoren und antivirusmitteln |
| US5789440A (en) * | 1993-11-19 | 1998-08-04 | Warner-Lambert Company | 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents |
| WO2015142903A2 (en) * | 2014-03-17 | 2015-09-24 | Genentech, Inc. | Method of controlling lactate production with piperdine-dione derivatives |
| MA39749A (fr) | 2014-03-17 | 2017-01-25 | Hoffmann La Roche | Dérivés de pipéridine-dione |
| EP3356331A1 (en) * | 2015-09-30 | 2018-08-08 | Selvita S.A. | Pyrazolidine derivatives and related compounds |
| GB201707852D0 (en) * | 2017-05-16 | 2017-06-28 | Arctic Pharma As | Compounds |
| GB201707846D0 (en) * | 2017-05-16 | 2017-06-28 | Spermatech As | Use |
-
2017
- 2017-05-16 GB GBGB1707856.9A patent/GB201707856D0/en not_active Ceased
-
2018
- 2018-05-16 EP EP18727384.2A patent/EP3625225B1/en active Active
- 2018-05-16 JP JP2020514351A patent/JP2020520388A/ja active Pending
- 2018-05-16 WO PCT/GB2018/051333 patent/WO2018211277A1/en not_active Ceased
- 2018-05-16 ES ES18727384T patent/ES2923652T3/es active Active
- 2018-05-16 US US16/613,837 patent/US11142520B2/en active Active
- 2018-05-16 CN CN201880034909.5A patent/CN110709393A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US11142520B2 (en) | 2021-10-12 |
| ES2923652T3 (es) | 2022-09-29 |
| CN110709393A (zh) | 2020-01-17 |
| EP3625225B1 (en) | 2022-06-29 |
| US20200165233A1 (en) | 2020-05-28 |
| WO2018211277A1 (en) | 2018-11-22 |
| EP3625225A1 (en) | 2020-03-25 |
| JP2020520388A (ja) | 2020-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201708456D0 (en) | Senolytic compounds | |
| GB201700814D0 (en) | Compounds | |
| GB201704327D0 (en) | Compounds | |
| GB201715342D0 (en) | Compounds | |
| GB201704325D0 (en) | Compounds | |
| GB201716871D0 (en) | Compounds | |
| GB201713962D0 (en) | Compounds | |
| GB201717051D0 (en) | Compounds | |
| GB201707938D0 (en) | Compounds | |
| GB201707856D0 (en) | Compounds | |
| GB201706162D0 (en) | Compounds | |
| GB201702221D0 (en) | Compounds | |
| GB201716369D0 (en) | Compounds | |
| GB201715786D0 (en) | Compounds | |
| GB201720064D0 (en) | Compounds | |
| GB201716392D0 (en) | Compounds | |
| GB201707852D0 (en) | Compounds | |
| GB201703282D0 (en) | Compounds | |
| GB201721330D0 (en) | Compounds | |
| GB201721326D0 (en) | Compounds | |
| GB201721331D0 (en) | Compounds | |
| GB201720495D0 (en) | ß-lactone compounds | |
| GB201719261D0 (en) | Compounds | |
| GB201717718D0 (en) | Compounds | |
| GB201717050D0 (en) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |